The third key concept of the New Neuropsychiatry is the importance of what we psychiatrists call 'remission.' In the past decade we have raised the bar, aiming for a higher goal of treatment. We have ...

Two-thirds of clinical trial participants treated with psilocybin-assisted therapy for major depressive disorder were in complete remission from their depression five years later, a new study has ...

Some patients still experience residual symptoms with an oral antidepressant (OAD), and one study even showed that one-third of patients did not achieve adequate symptom relief after multiple OADs.